SCHEMBL17865943

SCHEMBL17865943

COc1ccccc1CNc1ncnc2c1ccn2[C@H]1C[C@H](O)[C@@H](N(C)S(=O)(=O)O)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
LMNA P02545 3/20 0.45
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
MAPK1 P28482 4/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
GAA P10253 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
ALDH1A1 P00352 4/20 0.42
USP2 O75604 4/20 0.42
CYP1A2 P05177 4/20 0.42
CYP3A4 P08684 4/20 0.42
CYP2D6 P10635 4/20 0.42
TSHR P16473 3/20 0.42
CYP2C19 P33261 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17866004 0.88 AURKA (0.42) ADORA3ADORA2AADORA1AURKARPS6KB1
SCHEMBL17865956 0.86 NAE1 (0.43) KDM4ELMNATP53MAPTSMN1; SMN2
SCHEMBL17865967 0.86 AURKA (0.42) LMNAAURKARPS6KB1NAE1CA2
SCHEMBL17865941 0.85 NAE1 (0.49) KDM4ELMNATP53MAPTMAPK1
SCHEMBL5456441 0.84 KDM4E (0.52) KDM4ELMNATP53MAPTMAPK1
SCHEMBL191796 0.82 NAE1 (0.63) KDM4ELMNATP53MAPTAURKA
SCHEMBL17865958 0.82 TP53 (0.45) LMNATP53MAPTMAPK1POLB
SCHEMBL17865979 0.81 METTL3 (0.40) LMNATP53POLBADORA3NAE1
SCHEMBL10004855 0.81 ADK (0.47) KDM4EMAPTPOLBCYP3A4CYP2C19
SCHEMBL17865976 0.80 CCNA2 (0.44) ADORA3AURKARPS6KB1NAE1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2402334-B1 Inhibitors of E1 Activating Enzymes MILLENNIUM PHARM INC (US) 2016-06-29 EP claimed